Enhancing Upstream Processes for High-Yield, High-Quality AAV Vector Production Using a Novel In-House Cell Line
Diving Deeper: Using a SYBR Gold Capsid Ejection Assay as an Orthogonal Method of Measuring Potency and VP1 Deamidation in AAV9 Drug Product Samples
Accelerate Time to Clinic: A Platform and Analytics Approach
Preliminary results for the year ended 31 December 2024
17 April 2025
Leerink Partners Global Healthcare Conference 2025
11 March 2025
Preliminary Results for the year ended 31 December 2024
9th April 2025
Improving Manufacturing Conditions: Use of DOEs for Optimal LV Production
Webinar: Accelerating Viral Vector Manufacturing: The Use of Automation from Early Stage to QC Release
Comparison of 2 Emulsion-Based Digital PCR Systems: ddPCR from BioRad versus dPCR from Stilla, for Reliable Determination of AAV Genome Titre
Jefferies London Healthcare conference presentation 2024
19 November 2024
Jefferies London Healthcare conference presentation 2024
19 November 2024
Driving Innovation in Cell and Gene Therapy
